Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

TGF-beta2 specific phosphorothioate antisense oligodeoxynucleotide

EU orphan designation number: EU/3/02/091   
Active ingredient: TGF-beta2 specific phosphorothioate antisense oligodeoxynucleotide
Indication: Treatment of high-grade glioma
Sponsor: Dr Ulrich Granzer
Mauerkircherstrasse 105, 81925 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/03/2002 Orphan designation EMEA/OD/073/01 (2002)1293 of 22/03/2002
04/02/2014 Change of name and/or address of sponsor
07/09/2016 Transfer of orphan designation EMEA/OD/073/01/T/01 (2016)5741 of 05/09/2016